Track topics on Twitter Track topics that are important to you
Many players in the pharmaceutical industry have been feeling the pain of serialization solutions that are falling short. With forthcoming regulatory requirements, companies need to find serialization solutions that are right for them. Join this free webinar to learn about a serialization platform that comes with numerous immediate and long-term benefits.
TORONTO (PRWEB) August 15, 2019
Serialization deadlines in the US and European Union have finally passed. Now what? As serialization mandates become increasingly complex, and aggregation becomes fully applied in the United States in 2023, pharmaceutical companies are scrutinizing whether their current serialization software is the best long-term solution.
Until now, most regulations―including the Drug Supply Chain Security Act (DSCSA)―have required minimal system capabilities. In the coming months, serialization systems will be tested for their ability to handle aggregation data, facilitate integration with distribution (internal and third-party logistics providers), integrate with downstream customers and handle complicated regulatory reporting requirements, such as the European Union’s Falsified Medicines Directive (EU FMD) and the Russian Federal Law No. 425-FZ.
Many players in the pharmaceutical industry have been feeling the pain of serialization solutions that are falling short. With the largest packaging-line installation base of any vendor, OPTEL often hears about these struggles: over-promised and under-delivered capabilities; high rates of issues and bugs; and the unexpected need to pay for costly “optional” tools and third-party resources to maintain a validated, high-performing solution.
Join Ron Watkins, Product Owner at OPTEL and Bill Romano, Sales and Account Executive at OPTEL in a live session on Wednesday, September 11, 2019 at 9am EDT (2pm BST/UK) to better understand serialization options for global requirements. The featured speakers will discuss tested methodology and real-life case studies, as well as the immediate and longer-term benefits of moving to the OPTEL serialization platform.
For more information or to register for this free event, visit Understand Your Serialization Options and the Long and Short-term Benefit of Switching Providers.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
For the original version on PRWeb visit: https://www.prweb.com/releases/understand_your_serialization_options_and_the_long_and_short_term_benefit_of_switching_providers_upcoming_webinar_hosted_by_xtalks/prweb16507412.htmNEXT ARTICLE
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...